Boyd Corporation announced today that it acquired MBK Tape Solutions and its multi-layered adhesive products. MBK manufactures and develops complex multi-layered adhesive products that bond, mount, monitor and protect for stick-to-skin applications in the regulated medical industry. Pleasanton, California-based Boyd said in a news release that the acquisition strengthens its medical material science capability across […]
Bigfoot Biomedical announces trio of new senior hires
Bigfoot Biomedical announced today that it appointed three senior hires with experience in the diabetes and healthcare sectors. Milpitas, California–based Bigfoot hired Matthew Clemente as SVP of development, Robin A. Beadle as VP of marketing and Scott Snead as VP of national accounts. All three positions are newly created. Bigfoot said in a news release […]
Alfred E. Mann Foundation brings former Alcon, Siemens Healthineers execs into C-suite
The Alfred E. Mann Foundation for Scientific Research (AMF) today confirmed the appointment of two new senior executives. Los Angeles-based AMF appointed Charles Nelson as its new COO and Corey Dishmon as its chief legal officer/chief business officer. Nelson joins AMF from Alcon, where he oversaw the manufacturing science and technology organization. He is a […]
Medtronic Diabetes receives FDA warning over quality system requirement inadequacies
Medtronic (NYSE:MDT) announced today that it received an FDA warning letter after an inspection of its Diabetes Business. The company received the letter on Dec. 9 for its Northridge, California facility — the Medtronic Diabetes Business headquarters — following an inspection that concluded in July 2021. FDA’s warning letter to Medtronic focused on the inadequacy […]
Virta Health touts triple-digit growth with insurers as market shifts toward diabetes reversal
Virta Health announced today that it now works with more than 20 national and regional health plans, marking triple-digit growth. San Francisco-based Virta Health, which develops type 2 diabetes reversal technology, has now grown 133% year-over-year with large insurer customers that now offer its treatment to self-funded employer groups, including Humana and Providence Health Plan. […]
PharmaJet partner announces COVID-19 vaccine trial with needle-free injection tech
PharmaJet announced today that one of its pharmaceutical partners, Nykode Therapeutics, has begun a trial for a COVID-19 vaccine with PharmaJet’s needle-free injection technology. Nykode’s Phase 1/2 clinical trial will specifically address the emerging SARS-CoV-2 variants, with the DNA-based vaccines delivered intramuscularly with PharmaJet’s Stratis needle-free injection system. The vaccines are designed to be tailored […]
Aerogen inks partnership to deliver COVID-19 vaccine with its mesh aerosol delivery tech
Aerogen and CanSinoBio announced today that they entered a partnership to deliver the latter’s COVID-19 vaccine with Aerogen’s technology. Galway, Ireland-based Aerogen’s proprietary vibrating mesh aerosol drug delivery technology will be used to deliver CanSinoBio’s recombinant novel coronavirus vaccine — Convidecia — under the development and commercial supply partnership. Commercial terms for the partnership were […]
Former pediatric endocrinologist joins Medtronic’s diabetes business as medical affairs director
Medtronic (NYSE:MDT) announced this week that former pediatric endocrinologist Dr. Jennifer McVean has joined its diabetes business. McVean, a former pediatric endocrinologist for the University of Minnesota Physicians and an associate professor in the pediatrics department at the University of Minnesota Medical School, will take up a role aimed at augmenting Medtronic’s commitment to providing […]
Fareva, ApiJect ink 10-year licensing agreement on fill-finish production lines
Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year. Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments […]
Virpax reports positive non-human study results for topical spray film that treats chronic pain
Virpax Pharmaceuticals (NSDQ:VRPX) today reported positive results from a study of its Epoladerm treatment for chronic pain management. Berwyn, Pennsylvania-based Virpax designed Epoladerm, one of its lead investigational products, for managing pain associated with osteoarthritis of the knee. According to a news release, the company reported positive results following the completion of a toxicology and […]